MARCH 23, 2017Jennifer Barrett, Assistant EditorThe FDA granted accelerated approval to the first treatment for metastatic Merkel cell carcinoma (MCC). Accessed March 23, 2017. Further studies are needed, and are currently being conducted, to confirm Bavencio's efficacy.Bavencio's accelerated approval is based on clinical data from a trial including 88 patients with metastatic MCC who had been previously treated with at least 1 prior chemotherapy regimen. Released March 23, 2017. FDA website.
PhotoA rare cancer first linked to breast implants in 2011 has now been associated with nine deaths, the Food and addiction Administration said Tuesday. The deaths were not caused by breast cancer, the agency said, but by a rare malignancy in the immune system, anaplastic large-cell lymphoma. The problem is more likely to occur with textured implants, which have a pebbly surface, than with smooth implants, the agency said. But women receiving implants should be aware of the potential problem and the increased risk with textured implants, the agency says. In cases linked to implants, this rare form of cancer grows in the breast, usually in the capsule of scar tissue that forms around an implant.
collected by :Lucy William
No comments:
Post a Comment